Dimitrakopoulou-Strauss A - Search Results

1

Comparison of (18)F-FDG PET/CT and PET/MRI in patients with multiple myeloma.

Sachpekidis C, Hillengass J, Goldschmidt H, Mosebach J, Pan L, Schlemmer HP, Haberkorn U, Dimitrakopoulou-Strauss A. Sachpekidis C, et al. Am J Nucl Med Mol Imaging. 2015 Oct 12;5(5):469-78. eCollection 2015. Am J Nucl Med Mol Imaging. 2015. PMID: 26550538 Free PMC article.

2

Evaluation of tumour metabolism and multidrug resistance in patients with treated malignant lymphomas.

Dimitrakopoulou-Strauss A, Strauss LG, Goldschmidt H, Lorenz WJ, Maier-Borst W, van Kaick G. Dimitrakopoulou-Strauss A, et al. Eur J Nucl Med. 1995 May;22(5):434-42. doi: 10.1007/BF00839058. Eur J Nucl Med. 1995. PMID: 7641752

3

Chemotherapeutic management of head and neck malignancies with positron emission tomography.

Reisser C, Haberkorn U, Dimitrakopoulou-Strauss A, Seifert E, Strauss LG. Reisser C, et al. Arch Otolaryngol Head Neck Surg. 1995 Mar;121(3):272-6. doi: 10.1001/archotol.1995.01890030014003. Arch Otolaryngol Head Neck Surg. 1995. PMID: 7873142

4

[Positron emission tomography (PET) in diagnosis and therapy planning of malignant lymphoma].

Dimitrakopoulou-Strauss A, Strauss LG, Goldschmidt H, Hegenbart U, Irngartinger G, Oberdorfer F, van Kaick G. Dimitrakopoulou-Strauss A, et al. Radiologe. 1997 Jan;37(1):74-80. doi: 10.1007/s001170050179. Radiologe. 1997. PMID: 9157479 German.

5

Quantitative PET studies in pretreated melanoma patients: a comparison of 6-[18F]fluoro-L-dopa with 18F-FDG and (15)O-water using compartment and noncompartment analysis.

Dimitrakopoulou-Strauss A, Strauss LG, Burger C. Dimitrakopoulou-Strauss A, et al. J Nucl Med. 2001 Feb;42(2):248-56. J Nucl Med. 2001. PMID: 11216523 Free article.

6

Dynamic PET 18F-FDG studies in patients with primary and recurrent soft-tissue sarcomas: impact on diagnosis and correlation with grading.

Dimitrakopoulou-Strauss A, Strauss LG, Schwarzbach M, Burger C, Heichel T, Willeke F, Mechtersheimer G, Lehnert T. Dimitrakopoulou-Strauss A, et al. J Nucl Med. 2001 May;42(5):713-20. J Nucl Med. 2001. PMID: 11337565 Free article.

7

Quantitative evaluation of skeletal tumours with dynamic FDG PET: SUV in comparison to Patlak analysis.

Wu H, Dimitrakopoulou-Strauss A, Heichel TO, Lehner B, Bernd L, Ewerbeck V, Burger C, Strauss LG. Wu H, et al. Eur J Nucl Med. 2001 Jun;28(6):704-10. doi: 10.1007/s002590100511. Eur J Nucl Med. 2001. PMID: 11440030 Clinical Trial.

8

The role of quantitative (18)F-FDG PET studies for the differentiation of malignant and benign bone lesions.

Dimitrakopoulou-Strauss A, Strauss LG, Heichel T, Wu H, Burger C, Bernd L, Ewerbeck V. Dimitrakopoulou-Strauss A, et al. J Nucl Med. 2002 Apr;43(4):510-8. J Nucl Med. 2002. PMID: 11937595 Free article.

9

PET-FDG as predictor of therapy response in patients with colorectal carcinoma.

Dimitrakopoulou-Strauss A, Strauss LG, Rudi J. Dimitrakopoulou-Strauss A, et al. Q J Nucl Med. 2003 Mar;47(1):8-13. Q J Nucl Med. 2003. PMID: 12714949 Free article. Clinical Trial.

10

Shortened PET data acquisition protocol for the quantification of 18F-FDG kinetics.

Strauss LG, Dimitrakopoulou-Strauss A, Haberkorn U. Strauss LG, et al. J Nucl Med. 2003 Dec;44(12):1933-9. J Nucl Med. 2003. PMID: 14660719 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

200 results

Search Page

Filters